[Federal Register Volume 68, Number 73 (Wednesday, April 16, 2003)]
[Notices]
[Pages 18663-18664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-9277]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Disease; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel, 
Biomechanics & Inflammation in Osteoarthritis.
    Date: April 28, 2003.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892. (Telephone conference call)
    Contact Person: Richard J. Bartlett, Ph.D., Scientific Review 
Administrator, National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, Natcher Bldg./Bldg. 45, MSC 6500/Room 5AS-37B, 
Bethesda, MD 20892. (301) 594-4952.
    This notice is being published less than 15 days prior to the 
meeting due to the timing

[[Page 18664]]

limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: April 9, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-9277 Filed 4-15-03; 8:45 am]
BILLING CODE 4140-01-M